CD36 and Hyperglycemia: Supporting our findings, Sampson et al. [39] showed that CD36 expression was already elevated in monocytes of T2D patients under basal conditions, and that acute hyperglycemia did not further increase its expression, indicating long-term metabolic adaptation and possible saturation of regulatory mechanisms [39].